Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges-Reference-Cited by-同舟云学术

Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges

Published:2016-07 Issue:35 Volume:34 Page:4196-4204
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Yan Qin,Wu Linjuan,Chen Longyun,Qin Yali,Pan Zishu,Chen Mingzhou

Funder

China Natural Sciences Foundation

Major State Basic Research Development Program

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. An overview of the evolution of enterovirus 71 and its clinical and public health significance;McMinn;FEMS Microbiol Rev,2002

2. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system;Liu;PLoS ONE,2011

3. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences;Chan;Infect Genet Evol,2010

4. Neurologic complications in children with enterovirus 71 infection;Huang;N Engl J Med,1999

5. Clinical features, diagnosis, and management of enterovirus 71;Ooi;Lancet Neurol,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bioreactor-Based Yellow Fever Virus-like Particle Production Process with Integrated Process Analytical Technology Based on Transient Transfection;Viruses;2023-09-27

2. Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD);Biologicals;2022-09

3. Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses;Journal of Virology;2022-05-11

4. TAK − 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice;Vaccine;2022-05

5. Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice;Vaccine;2021-09